Highlights the risk of acute arterial thrombosis during Adriamycin-cyclophosphamide chemotherapy in breast cancer patients, requiring immediate anticoagulant and surgical intervention.
Despite the low risks of arterial thrombosis in breast cancer, it is a devastating complication with significant morbidity and mortality. Thromboprophylaxis should be considered in those at risk. Immediate anticoagulant therapy and surgical intervention should be considered in affected cases.
Jang et al. (Sun,) studied this question.